Does Prophylaxis Against Respiratory Syncytial Virus Infection Affect the Weight Percentiles of Infants with Hemodynamically Significant Congenital Heart Disease?

• Asıl Yazarlar: Ali Orgun (Yazar), İbrahim İlker Çetin (Yazar), Hazım Alper Gürsu (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Galenos Publishing House, 2021-08-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Objective: The risk of severe respiratory syncytial virus (RSV) infection with significant morbidity and mortality is greatest in patients with hemodynamically significant congenital heart disease (hs-CHD). The humanized monoclonal antibody, palivizumab, was used as prophylaxis for RSV infection in...